North America Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031

North America Wound Closure Devices Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Other Products), Wound Type (Chronic Wound and Acute Wound), and End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Other End Users)

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031
  • Report Code : TIPRE00041359
  • Category : Life Sciences
  • No. of Pages : 159
  • Available Report Formats : pdf-format excel-format
North America Wound Closure Device Market Analysis and Forecast by Size, Share, Growth, Trends 2031
Report Date: Oct 2025   |   Report Code: TIPRE00041359
Buy Now

The North America wound closure device market size is expected to reach US$ 8,053.77 million by 2031 from US$ 5,421.11 million in 2024. The market is estimated to record a CAGR of 5.9% from 2025-2031.

Executive Summary and North America Wound Closure Device Market Analysis:

The North America wound closure devices market is segmented into the US, Canada, and Mexico. The US possesses a significant market share in 2024, followed by Canada and Mexico. The wound closure devices market in this region is expected to grow due to rapid technological advancements, growing medical expenditure, increasing surgical procedures, and rising prevalence of chronic diseases leading to chronic wounds.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

North America Wound Closure Devices Market: Strategic Insights

north-america-wound-closure-device-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Wound Closure Device Market Segmentation Analysis:

Key segments that contributed to the derivation of the wound closure device market analysis are product, wound type, and end use.

  • By product, the wound closure device market is segmented into sutures, adhesives, staplers, strips, and others. The sutures segment held the largest share of the market in 2024.
  • By wound type, the wound closure device market is bifurcated into chronic wound and acute wound. The chronic wound segment held a larger share of the market in 2024.
  • By end use, the wound closure device market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2024.

North America Wound Closure Devices Market Report Scope

Report Attribute Details
Market size in 2024 US$ 5,421.11 Million
Market Size by 2031 US$ 8,053.77 Million
CAGR (2025 - 2031) 5.9%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Sutures
  • Staplers
  • Adhesives
  • Strips
  • Others
By Wound Type
  • Chronic Wound
  • Acute Wound
By End Use
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • B Braun SE
  • Johnson & Johnson
  • Medtronic Plc
  • 3M Co
  • Stryker Corp
  • Baxter International Inc
  • Meril Life Sciences Pvt Ltd
  • CooperSurgical, Inc
  • Smith & Nephew Plc
  • TI Medical
  • Futura Surgicare Pvt Ltd (Dolphin Sutures)
  • Corza Medical GmbH
  • Essity AB
  • Advanced Medical Solutions Group plc
  • Healthium Medtech Limited

North America Wound Closure Devices Market Players Density: Understanding Its Impact on Business Dynamics

The North America Wound Closure Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

north-america-wound-closure-device-market-cagr

North America Wound Closure Device Market Outlook

According to the World Health Organization (WHO), more than 300 million surgical procedures are performed annually around the globe. Also, the International Society of Aesthetic Plastic Surgery (ISAPS) presented the findings of its 2023 annual Global Survey on Aesthetic/Cosmetic Procedures at the ISAPS World Congress in Cartagena. The survey indicates a notable increase of 5.5% in surgical procedures, with plastic surgeons carrying out over 15.8 million procedures and non-surgical procedures totaling 19.1 million. Over the past four years, there has been an overall increase of 40%.

The rising demand for surgical procedures worldwide is one of the major growth drivers for the wound closure devices market. With an increasing number of surgeries, the demand for efficient and effective wound closure products increases. These include operations like C-sections, orthopedic procedures, and plastic surgeries, all of which need perfect wound closure methods to allow for proper healing and reduce complications.

Wound closure devices like sutures, staples, and newer adhesive strips assist in achieving improved results by facilitating quicker healing, lowering the risk of infection, and enhancing the cosmetic outcome of the operation. The growing number of surgeries in developing and developed countries, combined with advances in healthcare technology, is boosting the demand for innovative closure solutions for wounds. Owing to the above-mentioned factors, hospitals and specialty clinics are spending more on high-quality devices for wound closure, thereby supporting the growth of the market.

North America Wound Closure Device Market Country Insights

Based on country, the North America wound closure device market comprises the US, Canada, and Mexico. The US held the largest share in 2024.

The prevalence and incidence of diabetes are directly proportional to chronic wound prevalence and incidence. Chronic wounds associated with diabetes include foot, venous, and pressure ulcers. According to The International Journal of Tissue Repair and Regeneration, active or healed venous ulcers occur in 1% of the US population. As per the National Diabetes Statistics Report 2020, a publication of the Centers for Disease Control and Prevention (CDC), 34.2 million people of all ages in the US have diabetes, and ~1 million diabetics develop a foot ulcer each year, while 6-7 million diabetes patients develop ulcers in their lifetime. Thus, the rising incidence of diabetes and chronic wounds leads to an increase in demand for wound dressing and contributes to the wound closure devices market growth during the forecast period. The companies in the US are increasing their presence by following organic and inorganic strategies. In October 2021, Medline Industries announced an investment of US$ 77.5 million to build a new distribution center in Kansas. Thus, the increasing need for wound dressing indicates a substantial opportunity for the key players to develop wound care management with innovative products.

Company Profiles

Some of the key players operating in the market include Healthium Medtech Limited, Advanced Medical Solutions Group plc, Essity AB, Corza Medical GmbH, Futura Surgicare Pvt Ltd (Dolphin Sutures), TI Medical, Smith & Nephew Plc, CooperSurgical, Inc, Meril Life Sciences Pvt Ltd, Baxter International Inc, Stryker Corp, 3M Co, Medtronic Plc, Johnson & Johnson, and B Braun SE, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Wound Closure Device Market Research Methodology :

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

  • Company websites, annual reports, financial statements, broker analyses, and investor presentations.
  • Industry trade journals and other relevant publications.
  • Government documents, statistical databases, and market reports.
  • News articles, press releases, and webcasts specific to companies operating in the market.

Note:

All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

  • Validate and refine findings from secondary research.
  • Enhance the expertise and market understanding of the analysis team.
  • Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

  • Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
  • External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

in the market.

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA
Page Updated: Dec 2025